Half of These Lupus Patients Hit Remission on One Off-the-Shelf Dose
Adicet's off-the-shelf CAR-T put 54% of a small lupus trial into remission on a single dose. Then the stock dropped 22%.
Latest Tech Arcade stories, page 3: bite-size news on AI, startups, funding, chips, robotics and biotech, every story sourced.
Adicet's off-the-shelf CAR-T put 54% of a small lupus trial into remission on a single dose. Then the stock dropped 22%.
Precision Neuroscience closed an oversubscribed $250M Series D at a ~$1B valuation, betting its surface brain implant beats drilling into tissue.
Snorkel AI closed a $350M Series E at a $3.5B valuation, tripling in 16 months on a $375M revenue run rate. The bottleneck in AI is no longer compute, it's data hard enough to make models smarter.
Hubble Network raised $200M at a $1.6B valuation to connect standard, sub-50-cent Bluetooth chips directly to satellites — no SIM, no tower, no new radio.
Island just raised a $400M Series F at a $6.4B valuation for its enterprise browser — as AI agents turn the humble tab into the place companies police their software.
Anthropic will pay Akamai $11.6 billion over seven years — potentially $20 billion — for CPU cloud capacity to run Claude, and handed over a warrant for up to 5% of the company.
OpenEvidence raised $250M at a $15B valuation for an AI clinical-search tool that's free to the ~40% of U.S. doctors who use it — with pharma ads footing the bill.
Ultragenyx's Fayuvi is the first-ever treatment for Sanfilippo syndrome type A — a one-time gene therapy priced at $3.95 million.
Qualcomm's Snapdragon 8 Elite Gen 6 is the first phone chip to hit 5.0 GHz, built on 2nm — and Qualcomm split the flagship into two, locking the local AI behind the pricier Extreme.
Basecamp Research raised a $140M Series C led by S32, with Anthropic and Nvidia backing an AI trained on DNA from over a million barely-studied species to design medicine from scratch.
Portuguese-British drone maker Tekever raised $580M at a $6.4B valuation — roughly 5x its price from 16 months ago, on 50,000+ flight hours over Ukraine.
Snorkel AI raised $350M at a $3.5B valuation after its revenue jumped ~18x in a year selling the expert training data, rubrics, and RL environments AI labs are starved for.
AMD's market value pushed past $1 trillion for the first time as AI chip demand — and warrant deals with OpenAI and Meta — sent the stock up nearly 10%.
Rainmaker raised a $100M Series B to scale drone-based cloud seeding across the American West — and pitch data centers on offsetting their water use.
Impulse Space reopened its Series D with a $308M extension, pushing the round to $808M at a ~$5.4B valuation as its 2028 rideshare flights sell out.
Profound just raised $180M at a $1.8B valuation to get brands named inside AI answers - the new SEO for a world where people ask a chatbot instead of clicking blue links.
StepFun's Step 5 Preview scores 44 to GPT-5.6 Sol's 47 on the intelligence index at roughly one-seventh the output price, with full open weights due October 15.
Mazama Energy raised an oversubscribed $135M Series B to chase superhot geothermal power at 400°C — aiming for 10x the output from a fifth of the wells.
Crusoe closed a $3.9B Series F at a $30.9B valuation — roughly triple its worth ten months ago — by owning the whole chain from power plant to GPU. The scarce input in AI stopped being chips and became electricity.
The FDA approved Ultragenyx's Fayuvi, the first-ever treatment for Sanfilippo syndrome type A, a fatal childhood brain disease with zero prior options. The one-time gene therapy lists at $3.95 million.
Anthropic says Claude now leads 26% of its AI R&D work, up from under 1% in February, with roughly 30,000 agents running in parallel.
Dave Duffield built PeopleSoft and Workday. His third act, Ridgeline, just raised $250M at a $1.425B valuation to replace the six-to-nine legacy systems running the back office of asset managers with one AI-native platform.
D-Robotics closed a $400M Series C — the day's biggest raise — selling the chips and software inside 20+ rival robot makers, with 8M+ Sunrise chips already shipped.
CADDi's $114M Series D values the Tokyo-and-Chicago manufacturing-AI startup at $1.2 billion — a bet that factories' lost drawings are worth a fortune.